Skip to main content
Fig. 1 | BMC Medical Genetics

Fig. 1

From: Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3

Fig. 1

MiRNA-210 was overexpressed in HBV-associated cirrhosis and liver cancer. a The expression of miRNA-210 was significantly increased in liver tissues of the Cirrhosis and Liver cancer group. * P < 0.05 compared with the Control group. # P < 0.05 compared with the Cirrhosis group. b The expression of miRNA-210 expression was significantly increased in HepG2 and HepG2.2.15 cells. * P < 0.05 compared with HL-7702 cells. # P < 0.05 compared with HepG2 cells. The experiment was performed in triplicate, and data were expressed as mean ± standard deviation (SD)

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us